Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of LAF 237 on Glucose Kinetics in T2DM
NCT00230464Phase 3Completed
- Sponsor
- UT Health San Antonio
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Nov 2004; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00230464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230464.